vs
Nutex Health, Inc.（NUTX）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是Nutex Health, Inc.的1.2倍（$188.3M vs $151.7M），BRC Group Holdings, Inc.净利率更高（47.9% vs 7.8%，领先40.1%），BRC Group Holdings, Inc.同比增速更快（-21.9% vs -41.1%），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs -15.4%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
NUTX vs RILY — 直观对比
营收规模更大
RILY
是对方的1.2倍
$151.7M
营收增速更快
RILY
高出19.3%
-41.1%
净利率更高
RILY
高出40.1%
7.8%
两年增速更快
NUTX
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $188.3M |
| 净利润 | $11.8M | $90.3M |
| 毛利率 | 30.4% | 79.5% |
| 营业利润率 | 20.4% | 32.3% |
| 净利率 | 7.8% | 47.9% |
| 营收同比 | -41.1% | -21.9% |
| 净利润同比 | -80.8% | 1710.8% |
| 每股收益（稀释后） | $2.34 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXRILY
| Q4 25 | $151.7M | $188.3M | ||
| Q3 25 | $267.8M | $215.3M | ||
| Q2 25 | $244.0M | $188.2M | ||
| Q1 25 | $211.8M | $197.2M | ||
| Q4 24 | $257.6M | $241.0M | ||
| Q3 24 | $78.8M | $225.5M | ||
| Q2 24 | $76.1M | $256.0M | ||
| Q1 24 | $67.5M | $263.4M |
净利润NUTXRILY
| Q4 25 | $11.8M | $90.3M | ||
| Q3 25 | $55.4M | $91.1M | ||
| Q2 25 | $-17.7M | $139.5M | ||
| Q1 25 | $21.2M | $-10.0M | ||
| Q4 24 | $61.6M | $-5.6M | ||
| Q3 24 | $-8.8M | $-284.4M | ||
| Q2 24 | $-364.0K | $-433.6M | ||
| Q1 24 | $-364.0K | $-49.2M |
毛利率NUTXRILY
| Q4 25 | 30.4% | 79.5% | ||
| Q3 25 | 57.8% | 83.7% | ||
| Q2 25 | 51.2% | 81.3% | ||
| Q1 25 | 55.9% | 81.4% | ||
| Q4 24 | 55.0% | 79.8% | ||
| Q3 24 | 27.8% | 82.1% | ||
| Q2 24 | 29.7% | 84.5% | ||
| Q1 24 | 15.1% | 85.3% |
营业利润率NUTXRILY
| Q4 25 | 20.4% | 32.3% | ||
| Q3 25 | 48.7% | 30.4% | ||
| Q2 25 | 13.8% | 5.7% | ||
| Q1 25 | 38.1% | -31.2% | ||
| Q4 24 | 44.4% | -69.2% | ||
| Q3 24 | 12.3% | -36.4% | ||
| Q2 24 | 7.0% | -90.8% | ||
| Q1 24 | 2.1% | -6.1% |
净利率NUTXRILY
| Q4 25 | 7.8% | 47.9% | ||
| Q3 25 | 20.7% | 42.3% | ||
| Q2 25 | -7.3% | 74.1% | ||
| Q1 25 | 10.0% | -5.1% | ||
| Q4 24 | 23.9% | -2.3% | ||
| Q3 24 | -11.2% | -126.1% | ||
| Q2 24 | -0.5% | -169.4% | ||
| Q1 24 | -0.5% | -18.7% |
每股收益（稀释后）NUTXRILY
| Q4 25 | $2.34 | $2.78 | ||
| Q3 25 | $7.76 | $2.91 | ||
| Q2 25 | $-2.95 | $4.50 | ||
| Q1 25 | $3.33 | $-0.39 | ||
| Q4 24 | $11.56 | $-0.01 | ||
| Q3 24 | $-1.72 | $-9.39 | ||
| Q2 24 | $-0.07 | $-14.35 | ||
| Q1 24 | $-0.08 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $329.4M | $-171.5M |
| 总资产 | $918.5M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUTXRILY
| Q4 25 | $185.6M | $226.6M | ||
| Q3 25 | $166.0M | $184.2M | ||
| Q2 25 | $96.7M | $267.4M | ||
| Q1 25 | $84.7M | $138.3M | ||
| Q4 24 | $40.6M | $146.9M | ||
| Q3 24 | $46.9M | $159.2M | ||
| Q2 24 | $40.8M | $236.9M | ||
| Q1 24 | $30.0M | $190.7M |
总债务NUTXRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NUTXRILY
| Q4 25 | $329.4M | $-171.5M | ||
| Q3 25 | $317.2M | $-260.5M | ||
| Q2 25 | $235.3M | $-351.7M | ||
| Q1 25 | $176.9M | $-496.8M | ||
| Q4 24 | $132.4M | $-488.2M | ||
| Q3 24 | $60.4M | $-497.6M | ||
| Q2 24 | $62.7M | $-218.3M | ||
| Q1 24 | $63.0M | $228.4M |
总资产NUTXRILY
| Q4 25 | $918.5M | $1.7B | ||
| Q3 25 | $964.5M | $1.7B | ||
| Q2 25 | $841.0M | $1.5B | ||
| Q1 25 | $761.9M | $1.5B | ||
| Q4 24 | $655.3M | $1.8B | ||
| Q3 24 | $438.5M | $2.2B | ||
| Q2 24 | $422.4M | $3.2B | ||
| Q1 24 | $404.3M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $69.0M | — |
| 自由现金流率自由现金流/营收 | 45.5% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 5.95× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $245.6M | — |
8季度趋势，按日历期对齐
经营现金流NUTXRILY
| Q4 25 | $70.4M | $26.2M | ||
| Q3 25 | $99.5M | $-60.6M | ||
| Q2 25 | $27.3M | $-25.6M | ||
| Q1 25 | $51.0M | $184.0K | ||
| Q4 24 | $54.0K | $-2.7M | ||
| Q3 24 | $6.8M | $19.5M | ||
| Q2 24 | $13.3M | $111.5M | ||
| Q1 24 | $3.1M | $135.4M |
自由现金流NUTXRILY
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $2.3M | — |
自由现金流率NUTXRILY
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 3.4% | — |
资本支出强度NUTXRILY
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.1% | — |
现金转化率NUTXRILY
| Q4 25 | 5.95× | 0.29× | ||
| Q3 25 | 1.80× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
